

Net Realized Capital Gains (Losses)
	Three Months Ended March 31,
(Before tax)	2017			2016
Gross gains on sales	$	112		$	90
Gross losses on sales	(75		)	(108		)
Net OTTI losses recognized in earnings	(1		)	(23		)
Results of variable annuity hedge program
GMWB derivatives, net	18			(17		)
Macro hedge program	(86		)	(14		)
Total results of variable annuity hedge program	(68		)	(31		)
Transactional foreign currency revaluation	(13		)	(44		)
Non-qualifying foreign currency derivatives	11			39
Other, net [1]	14			(78		)
Net realized capital gains (losses)	$	(20	)	$	(155	)


[1]	Includes non-qualifying derivatives, excluding variable annuity hedge program and foreign currency derivatives, of $10 and $(37), respectively for the three months ended March 31, 2017 and 2016.

Net realized capital gains and losses from investment sales are reported as a component of revenues and are determined on a specific identification basis. Before tax, net gains (and losses) on sales and impairments previously reported as unrealized gains (or losses) in AOCI were $36 and $41 for the three months ended March 31, 2017 and 2016, respectively. Proceeds from sales of AFS securities totaled $6.7 billion and $4.9 billion for the three months ended March 31, 2017 and 2016, respectively.

Recognition and Presentation of Other-Than-Temporary Impairments

The Company will record an other-than-temporary impairment (“OTTI”) for fixed maturities and certain equity securities with debt-like characteristics (collectively “debt securities”) if the Company intends to sell or it is more likely than not that the Company will be required to sell the security before a recovery in value. A corresponding charge is recorded in net realized capital losses equal to the difference between the fair value and amortized cost basis of the security.

The Company will also record an OTTI for those debt securities for which the Company does not expect to recover the entire amortized cost basis. For these securities, the excess of the amortized cost basis over its fair value is separated into the portion representing a credit OTTI, which is recorded in net realized capital losses, and the remaining non-credit amount, which is recorded in OCI. The credit OTTI amount is the excess of its amortized cost basis over the Company’s best estimate of discounted expected future cash flows. The non-credit amount is the excess of the best estimate of the discounted expected future cash flows over the fair value. The Company’s best estimate of discounted expected future cash flows becomes the new cost basis and accretes prospectively into net investment income over the estimated remaining life of the security.

The Company’s best estimate of expected future cash flows is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions regarding the future performance. The Company considers, but is not limited to (a) changes in the financial condition of the issuer and the underlying collateral, (b) whether the issuer is current on contractually obligated interest and principal payments, (c) credit ratings, (d) payment structure of the security and (e) the extent to which the fair value has been less than the amortized cost of the security.

For non-structured securities, assumptions include, but are not limited to, economic and industry-specific trends and fundamentals, security-specific developments, industry earnings multiples and the issuer’s ability to restructure and execute asset sales.

For structured securities, assumptions include, but are not limited to, various performance indicators such as historical and projected default and recovery rates, credit ratings, current and projected delinquency rates, loan-to-value ("LTV") ratios, average cumulative collateral loss rates that vary by vintage year, prepayment speeds, and property value declines. These assumptions require the use of significant management judgment and include the probability of issuer default and estimates regarding timing and amount of expected recoveries which may include estimating the underlying collateral value.

The Company will also record an OTTI for equity securities where the decline in the fair value is deemed to be other-than-temporary. A corresponding charge is recorded in net realized capital losses equal to the difference between the fair value and cost basis of the security. The previous cost basis less the impairment becomes the new cost basis. The Company’s evaluation and assumptions used to determine an equity OTTI include, but is not limited to, (a) the length of time and extent to which the fair value has been less than the cost of the security, (b) changes in the financial condition, credit rating and near-term prospects of the issuer, (c) whether the issuer is current on preferred stock dividends and (d) the intent and ability of the Company to retain the investment for a period of time sufficient to allow for recovery. For the remaining equity securities which are determined to be temporarily impaired, the Company asserts its intent and ability to retain those equity securities until the price recovers.



Impairments in Earnings by Type
	Three Months Ended March 31,
	2017		2016
Credit impairments	$	1	$	18
Intent-to-sell impairments	—		2
Impairments on equity securities	—		3
Total impairments	$	1	$	23



Cumulative Credit Impairments
	Three Months Ended March 31,
(Before tax)	2017			2016
Balance as of beginning of period	$	(280	)	$	(324	)
Additions for credit impairments recognized on [1]:
Securities not previously impaired	(1		)	(17		)
Securities previously impaired	—			(1		)
Reductions for credit impairments previously recognized on:
Securities that matured or were sold during the period	12			1
Securities due to an increase in expected cash flows	9			5
Balance as of end of period	$	(260	)	$	(336	)


[1]	These additions are included in the net OTTI losses recognized in earnings in the Condensed Consolidated Statements of Operations.

Available-for-Sale Securities



AFS Securities by Type
	March 31, 2017												December 31, 2016
	Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Non-Credit OTTI [1]			Cost or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Non-Credit OTTI [1]
ABS	$	2,267	$	20	$	(22	)	$	2,265	$	—		$	2,396	$	17	$	(31	)	$	2,382	$	—
CDOs [2]	2,243		71		(3		)	2,311		—			1,853		67		(4		)	1,916		—
CMBS	5,055		102		(58		)	5,099		(7		)	4,907		97		(68		)	4,936		(6		)
Corporate	24,371		1,548		(189		)	25,730		—			24,380		1,510		(224		)	25,666		—
Foreign govt./govt. agencies	1,151		48		(12		)	1,187		—			1,164		33		(26		)	1,171		—
Municipal	11,076		759		(55		)	11,780		—			10,825		732		(71		)	11,486		—
RMBS	3,866		69		(14		)	3,921		—			4,738		66		(37		)	4,767		—
U.S. Treasuries	3,879		189		(35		)	4,033		—			3,542		182		(45		)	3,679		—
Total fixed maturities, AFS	$	53,908	$	2,806	$	(388	)	$	56,326	$	(7	)	$	53,805	$	2,704	$	(506	)	$	56,003	$	(6	)
Equity securities, AFS [3]	1,011		107		(18		)	1,100		—			1,020		96		(19		)	1,097		—
Total AFS securities	$	54,919	$	2,913	$	(406	)	$	57,426	$	(7	)	$	54,825	$	2,800	$	(525	)	$	57,100	$	(6	)


[1]	Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses as of March 31, 2017, and December 31, 2016.


[2]	Gross unrealized gains (losses) exclude the fair value of bifurcated embedded derivatives within certain securities. Subsequent changes in value are recorded in net realized capital gains (losses).


[3]	Excludes equity securities, FVO, with a cost and fair value of $124 and $123 as of March 31, 2017. The Company held no equity securities, FVO as of December 31, 2016.



Fixed maturities, AFS, by Contractual Maturity Year
	March 31, 2017				December 31, 2016
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
One year or less	$	1,693	$	1,709	$	1,896	$	1,912
Over one year through five years	9,145		9,422		9,015		9,289
Over five years through ten years	9,079		9,325		9,038		9,245
Over ten years	20,560		22,274		19,962		21,556
Subtotal	40,477		42,730		39,911		42,002
Mortgage-backed and asset-backed securities	13,431		13,596		13,894		14,001
Total fixed maturities, AFS	$	53,908	$	56,326	$	53,805	$	56,003

Estimated maturities may differ from contractual maturities due to security call or prepayment provisions. Due to the potential for variability in payment speeds (i.e. prepayments or extensions), mortgage-backed and asset-backed securities are not categorized by contractual maturity.

Concentration of Credit Risk

The Company aims to maintain a diversified investment portfolio including issuer, sector and geographic stratification, where applicable, and has established certain exposure limits, diversification standards and review procedures to mitigate credit risk. The Company had no investment exposure to any credit concentration risk of a single issuer greater than 10% of the Company's stockholders' equity, other than the U.S. government and certain U.S. government agencies as of March 31, 2017 and December 31, 2016.

Unrealized Losses on AFS Securities



Unrealized Loss Aging for AFS Securities by Type and Length of Time as of March 31, 2017
	Less Than 12 Months							12 Months or More							Total
	Amortized Cost		Fair Value		Unrealized Losses			Amortized Cost		Fair Value		Unrealized Losses			Amortized Cost		Fair Value		Unrealized Losses
ABS	$	544	$	542	$	(2	)	$	276	$	256	$	(20	)	$	820	$	798	$	(22	)
CDOs [1]	1,253		1,251		(2		)	284		283		(1		)	1,537		1,534		(3		)
CMBS	1,804		1,764		(40		)	309		291		(18		)	2,113		2,055		(58		)
Corporate	4,813		4,671		(142		)	865		818		(47		)	5,678		5,489		(189		)
Foreign govt./govt. agencies	350		341		(9		)	36		33		(3		)	386		374		(12		)
Municipal	1,372		1,318		(54		)	35		34		(1		)	1,407		1,352		(55		)
RMBS	865		856		(9		)	453		448		(5		)	1,318		1,304		(14		)
U.S. Treasuries	1,425		1,390		(35		)	—		—		—			1,425		1,390		(35		)
Total fixed maturities, AFS	$	12,426	$	12,133	$	(293	)	$	2,258	$	2,163	$	(95	)	$	14,684	$	14,296	$	(388	)
Equity securities, AFS [2]	238		223		(15		)	30		27		(3		)	268		250		(18		)
Total securities in an unrealized loss position	$	12,664	$	12,356	$	(308	)	$	2,288	$	2,190	$	(98	)	$	14,952	$	14,546	$	(406	)



Unrealized Loss Aging for AFS Securities by Type and Length of Time as of December 31, 2016
	Less Than 12 Months							12 Months or More							Total
	Amortized Cost		Fair Value		Unrealized Losses			Amortized Cost		Fair Value		Unrealized Losses			Amortized Cost		Fair Value		Unrealized Losses
ABS	$	582	$	579	$	(3	)	$	368	$	340	$	(28	)	$	950	$	919	$	(31	)
CDOs [1]	641		640		(1		)	370		367		(3		)	1,011		1,007		(4		)
CMBS	2,076		2,027		(49		)	293		274		(19		)	2,369		2,301		(68		)
Corporate	5,418		5,248		(170		)	835		781		(54		)	6,253		6,029		(224		)
Foreign govt./govt. agencies	573		550		(23		)	27		24		(3		)	600		574		(26		)
Municipal	1,567		1,498		(69		)	43		41		(2		)	1,610		1,539		(71		)
RMBS	1,655		1,624		(31		)	591		585		(6		)	2,246		2,209		(37		)
U.S. Treasuries	1,432		1,387		(45		)	—		—		—			1,432		1,387		(45		)
Total fixed maturities, AFS	$	13,944	$	13,553	$	(391	)	$	2,527	$	2,412	$	(115	)	$	16,471	$	15,965	$	(506	)
Equity securities, AFS [2]	330		315		(15		)	38		34		(4		)	368		349		(19		)
Total securities in an unrealized loss position	$	14,274	$	13,868	$	(406	)	$	2,565	$	2,446	$	(119	)	$	16,839	$	16,314	$	(525	)


[1]	Unrealized losses exclude the change in fair value of bifurcated embedded derivatives within certain securities, for which changes in fair value are recorded in net realized capital gains (losses).


[2]	As of March 31, 2017, excludes equity securities, FVO which are included in equity securities, AFS on the Condensed Consolidated Balance Sheets. The Company held no equity securities, FVO as of December 31, 2016.

As of March 31, 2017, AFS securities in an unrealized loss position consisted of 3,528 securities, primarily in the corporate sector, which were depressed primarily due to an increase in interest rates and/or widening of credit spreads since the securities were purchased. As of March 31, 2017, 94% of these securities were depressed less than 20% of cost or amortized cost. The decrease in unrealized losses during first quarter 2017 was primarily attributable to a decline in long-term interest rates as well as tighter credit spreads across most sectors.

Most of the securities depressed for twelve months or more relate to corporate securities primarily in the financial services and energy-related sectors, student loan ABS and structured securities with exposure to commercial real estate. Corporate financial services securities and student loan ABS were primarily depressed because the securities have floating-rate coupons and have long-dated maturities, and current credit spreads are wider than when these securities were purchased. Corporate securities within the energy sector are in an unrealized loss position primarily due to depressed oil prices. For certain commercial real estate securities, current spreads are wider than market spreads at the securities' respective purchase dates. The Company neither has an intention to sell nor does it expect to be required to sell the securities outlined in the preceding discussion.

Mortgage Loans

Mortgage Loan Valuation Allowances

Commercial mortgage loans are considered to be impaired when management estimates that, based upon current information and events, it is probable that the Company will be unable to collect amounts due according to the contractual terms of the loan agreement. The Company reviews mortgage loans on a quarterly basis to identify potential credit losses. Among other factors, management reviews current and projected macroeconomic trends, such as unemployment rates and property-specific factors such as rental rates, occupancy levels, LTV ratios and debt service coverage ratios (“DSCR”). In addition, the Company considers historical, current and projected delinquency rates and property values. Estimates of collectibility require the use of significant management judgment and include the probability and timing of borrower default and loss severity estimates. In addition, cash flow projections may change based upon new information about the borrower's ability to pay and/or the value of underlying collateral such as changes in projected property value estimates.

For mortgage loans that are deemed impaired, a valuation allowance is established for the difference between the carrying amount and estimated fair value. The mortgage loan's estimated fair value is most frequently the Company's share of the fair value of the collateral but may also be the Company’s share of either (a) the present value of the expected future cash flows discounted at the loan’s effective interest rate or (b) the loan’s observable market price. A valuation allowance may be recorded for an individual loan or for a group of loans that have an LTV ratio of 90% or greater, a low DSCR or have other lower credit quality characteristics. Changes in valuation allowances are recorded in net realized capital gains and losses. Interest income on impaired loans is accrued to the extent it is deemed collectible and the borrowers continue to make payments under the original or restructured loan terms. The Company stops accruing interest income on loans when it is probable that the Company will not receive interest and principal payments according to the contractual terms of the loan agreement. The Company resumes accruing interest income when it determines that sufficient collateral exists to satisfy the full amount of the loan principal and interest payments and when it is probable cash will be received in the foreseeable future. Interest income on defaulted loans is recognized when received.

As of March 31, 2017 and December 31, 2016, commercial mortgage loans had an amortized cost of $5.7 billion, with a valuation allowance of $19 and a carrying value of $5.7 billion.

As of March 31, 2017 and December 31, 2016, the carrying value of mortgage loans that had a valuation allowance was $57 and $31, respectively. There were no mortgage loans held-for-sale as of March 31, 2017 or December 31, 2016. As of March 31, 2017, the Company had an immaterial amount of mortgage loans that have had extensions or restructurings other than what is allowable under the original terms of the contract.

The following table presents the activity within the Company’s valuation allowance for mortgage loans. These loans have been evaluated both individually and collectively for impairment. Loans evaluated collectively for impairment are immaterial.



Valuation Allowance Activity
	2017			2016
Balance, as of January 1	$	(19	)	$	(23	)
(Additions)/Reversals	—			—
Deductions	—			1
Balance, as of March 31	$	(19	)	$	(22	)

The weighted-average LTV ratio of the Company’s commercial mortgage loan portfolio was 51% as of March 31, 2017, while the weighted-average LTV ratio at origination of these loans was 62%. LTV ratios compare the loan amount to the value of the underlying property collateralizing the loan. The loan collateral values are updated no less than annually through reviews of the underlying properties. Factors considered in estimating property values include, among other things, actual and expected property cash flows, geographic market data and the ratio of the property's net operating income to its value. DSCR compares a property’s net operating income to the borrower’s principal and interest payments. The weighted average DSCR of the Company's commercial mortgage loan portfolio was 2.67x as of March 31, 2017. As of March 31, 2017, the Company held two delinquent commercial mortgage loan past due by 90 days or more. The loans had a total carrying value and valuation allowance of $27 and $18, respectively, and neither loan was accruing income. As of December 31, 2016, the Company held one delinquent commercial mortgage loans past due by 90 days or more. The loan had a total carrying value and valuation allowance of $15 and $16, respectively, and was not accruing income.



Commercial Mortgage Loans Credit Quality
	March 31, 2017			December 31, 2016
Loan-to-value	Carrying Value		Avg. Debt-Service Coverage Ratio	Carrying Value		Avg. Debt-Service Coverage Ratio
Greater than 80%	$	21	0.59x	$	20	0.59x
65% - 80%	524		2.20x	568		2.17x
Less than 65%	5,140		2.74x	5,109		2.78x
Total commercial mortgage loans	$	5,685	2.67x	$	5,697	2.70x



Mortgage Loans by Region
	March 31, 2017				December 31, 2016
	Carrying Value		Percent of Total		Carrying Value		Percent of Total
East North Central	$	293	5.2	%	$	293	5.1	%
East South Central	14		0.2	%	14		0.2	%
Middle Atlantic	557		9.8	%	534		9.4	%
Mountain	61		1.1	%	61		1.1	%
New England	389		6.8	%	345		6.1	%
Pacific	1,604		28.2	%	1,609		28.3	%
South Atlantic	1,217		21.4	%	1,198		21.0	%
West North Central	40		0.7	%	40		0.7	%
West South Central	347		6.1	%	338		5.9	%
Other [1]	1,163		20.5	%	1,265		22.2	%
Total mortgage loans	$	5,685	100.0	%	$	5,697	100.0	%


[1]	Primarily represents loans collateralized by multiple properties in various regions.



Mortgage Loans by Property Type
	March 31, 2017				December 31, 2016
	Carrying Value		Percent of Total		Carrying Value		Percent of Total
Commercial
Agricultural	$	16	0.3	%	$	16	0.3	%
Industrial	1,397		24.6	%	1,468		25.7	%
Lodging	25		0.4	%	25		0.4	%
Multifamily	1,372		24.1	%	1,365		24.0	%
Office	1,427		25.1	%	1,361		23.9	%
Retail	1,012		17.8	%	1,036		18.2	%
Other	436		7.7	%	426		7.5	%
Total mortgage loans	$	5,685	100.0	%	$	5,697	100.0	%

Mortgage Servicing

The Company originates, sells and services commercial mortgage loans on behalf of third parties and recognizes servicing fee income over the period that services are performed. As of March 31, 2017, under this program, the Company serviced commercial mortgage loans with a total outstanding principal of $983, of which $266 was serviced on behalf of third parties and $717 was retained and reported on the Company’s Condensed Consolidated Balance Sheets, including $143 in separate account assets. As of December 31, 2016, the Company serviced commercial mortgage loans with a total outstanding principal balance of $901, of which $251 was serviced on behalf of third parties and $650 was retained and reported as assets on the Company’s Condensed Consolidated Balance Sheets, including $124 in separate account assets. Servicing rights are carried at the lower of cost or fair value and were zero as of March 31, 2017 and December 31, 2016, because servicing fees were market-level fees at origination and remain adequate to compensate the Company for servicing the loans.

Variable Interest Entities

The Company is engaged with various special purpose entities and other entities that are deemed to be VIEs primarily as an investor through normal investment activities but also as an investment manager and previously as a means of accessing capital through a contingent capital facility ("facility").

A VIE is an entity that either has investors that lack certain essential characteristics of a controlling financial interest, such as simple majority kick-out rights, or lacks sufficient funds to finance its own activities without financial support provided by other entities. The Company performs ongoing qualitative assessments of its VIEs to determine whether the Company has a controlling financial interest in the VIE and therefore is the primary beneficiary. The Company is deemed to have a controlling financial interest when it has both the ability to direct the activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. Based on the Company’s assessment, if it determines it is the primary beneficiary, the Company consolidates the VIE in the Company’s Condensed Consolidated Financial Statements.

Consolidated VIEs

As of March 31, 2017 and December 31, 2016, the Company held one CDO for which it is the primarily beneficiary. The CDO represents a structured investment vehicle for which the Company has a controlling financial interest. As of March 31, 2017 and December 31, 2016 the Company held total CDO assets of $5 included in cash with an associated liability of $5 included in other liabilities on the Company's Condensed Consolidated Balance Sheets. The Company does not have any additional exposure to loss associated with this investment.

Non-Consolidated VIEs

The Company, through normal investment activities, makes passive investments in limited partnerships and other alternative investments. For these non-consolidated VIEs, the Company has determined it is not the primary beneficiary as it has no ability to direct activities that could significantly affect the economic performance of the investments. The Company’s maximum exposure to loss as of March 31, 2017 and December 31, 2016 is limited to the total carrying value of $1.7 billion which are included in limited partnerships and other alternative investments in the Company's Condensed Consolidated Balance Sheets. As of March 31, 2017 and December 31, 2016, the Company has outstanding commitments totaling $1.1 billion and $1.2 billion, respectively, whereby the Company is committed to fund these investments and may be called by the partnership during the commitment period to fund the purchase of new investments and partnership expenses. These investments are generally of a passive nature in that the Company does not take an active role in management. For further discussion of these investments, see Equity Method Investments within Note 6 - Investments of Notes to Consolidated Financial Statements included in the Company’s 2016 Form 10-K Annual Report.

In addition, the Company also makes passive investments in structured securities issued by VIEs for which the Company is not the manager and, therefore, does not consolidate. These investments are included in ABS, CDOs, CMBS and RMBS in the Available-for-Sale Securities table and fixed maturities, FVO, in the Company’s Condensed Consolidated Balance Sheets. The Company has not provided financial or other support with respect to these investments other than its original investment. For these investments, the Company determined it is not the primary beneficiary due to the relative size of the Company’s investment in comparison to the principal amount of the structured securities issued by the VIEs, the level of credit subordination which reduces the Company’s obligation to absorb losses or right to receive benefits and the Company’s inability to direct the activities that most significantly impact the economic performance of the VIEs. The Company’s maximum exposure to loss on these investments is limited to the amount of the Company’s investment.

As of December 31, 2016, the Company held a significant variable interest in a VIE for which it is not the primary beneficiary. This VIE represented a facility that was held by the Company since February 2007. Assets and liabilities recorded for the contingent capital facility were $1 and $3, respectively, as of December 31, 2016. as well as a maximum exposure to loss of $3. The Company did not have a controlling financial interest and as such, did not consolidate its variable interest in the facility. As of March 31, 2017, after having exercised its put option under the facility to issue debt, the Company no longer held a significant interest in the facility. For further information on the facility, see Note 10 - Debt of Notes to Condensed Consolidated Financial Statements.

Securities Lending, Repurchase Agreements and Other Collateral Transactions

The Company enters into securities financing transactions as a way to earn additional income or manage liquidity, primarily through securities lending and repurchase agreements.

Securities Lending

Under a securities lending program, the Company lends certain fixed maturities within the corporate, foreign government/government agencies, and municipal sectors as well as equity securities to qualifying third-party borrowers in return for collateral in the form of cash or securities. For domestic and non-domestic loaned securities, respectively, borrowers provide collateral of 102% and 105% of the fair value of the securities lent at the time of the loan. Borrowers will return the securities to the Company for cash or securities collateral at maturity dates generally of 90 days or less. Security collateral on deposit from counterparties in connection with securities lending transactions may not be sold or re-pledged, except in the event of default by the counterparty, and is not reflected on the Company’s Condensed Consolidated Balance Sheets. Additional collateral is obtained if the fair value of the collateral falls below 100% of the fair value of the loaned securities. The agreements provide the counterparty the right to sell or re-pledge the securities loaned. If cash, rather than securities, is received as collateral, the cash is typically invested in short-term investments or fixed maturities and is reported as an asset on the Company's Condensed Consolidated Balance Sheets. Income associated with securities lending transactions is reported as a component of net investment income in the Company’s Condensed Consolidated Statements of Operations. As of March 31, 2017, the fair value of securities on loan and the associated liability for cash collateral received was $1.5 billion and $1.5 billion, respectively. The Company also received securities collateral of $59 which was not included on the Company's Condensed Consolidated Balance Sheets. As of December 31, 2016, the fair value of securities on loan and the associated liability for cash collateral received was $488 and $461, respectively. The Company also received securities collateral of $39 which was not included on the Company's Condensed Consolidated Balance Sheets.

Repurchase Agreements

From time to time, the Company enters into repurchase agreements to manage liquidity or to earn incremental income. A repurchase agreement is a transaction in which one party (transferor) agrees to sell securities to another party (transferee) in return for cash (or securities), with a simultaneous agreement to repurchase the same securities at a specified price at a later date. These transactions generally have a contractual maturity of ninety days or less.

Under repurchase agreements, the Company transfers collateral of U.S. government and government agency securities and receives cash. For repurchase agreements, the Company obtains cash in an amount equal to at least 95% of the fair value of the securities transferred. The agreements require additional collateral to be transferred when necessary and provide the counterparty the right to sell or re-pledge the securities transferred. The cash received from the repurchase program is typically invested in short-term investments or fixed maturities and is reported as an asset on the Company's Condensed Consolidated Balance Sheets. Repurchase agreements include master netting provisions that provide both counterparties the right to offset claims and apply securities held by them with respect to their obligations in the event of a default. Although the Company has the contractual right to offset claims, fixed maturities do not meet the specific conditions for net presentation under U.S. GAAP. The Company accounts for the repurchase agreements as collateralized borrowings. The securities transferred under repurchase agreements are included in fixed maturities, AFS with the obligation to repurchase those securities recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets.

As of March 31, 2017 and December 31, 2016, the Company reported in fixed maturities, AFS on the Condensed Consolidated Balances Sheets financial collateral pledged relating to repurchase agreements of $318 and $226, respectively. As of December 31, 2016, the Company also reported cash collateral pledged relating to repurchase agreements of $22 . The Company reported a corresponding obligation to repurchase the pledged securities of $313 and $241 , respectively, as of March 31, 2017 and December 31, 2016 in other liabilities on the Condensed Consolidated Balance Sheets.

Under reverse repurchase agreements, the Company purchases securities and simultaneously agrees to resell the same or substantially the same securities. The agreements require additional collateral to be transferred to the Company when necessary and the Company has the right to sell or re-pledge the securities received. The Company accounts for reverse repurchase agreements as collateralized financing. As of March 31, 2017, the Company reported $96 within short-term investments on the Condensed Consolidated Balance Sheets representing a receivable for the amount of cash transferred to purchase the securities. The Company did not hold any reverse repurchase agreements as of December 31, 2016.

Other Agreements

The Company is required by law to deposit securities with government agencies in certain states in which it conducts business. As of March 31, 2017 and December 31, 2016, the fair value of securities on deposit was approximately $2.5 billion.

As of March 31, 2017 and December 31, 2016, the Company has pledged as collateral $104 and $102, respectively, of U.S. government securities and government agency securities or cash primarily related to certain bank loan participations committed to through a limited partnership agreement. These amounts also include collateral related to letters of credit.

For disclosure of collateral in support of derivative transactions, refer to the Derivative Collateral Arrangements section of Note 7 - Derivative Instruments of Notes to Condensed Consolidated Financial Statements.